Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies-Reference-Cited by-同舟云学术

Clinical efficacy and safety of arbekacin for high-risk infections in patients with hematological malignancies

Published:2015-12-29 Issue:3 Volume:103 Page:334-340
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Miura Katsuhiro,Nakagawa Masaru,Takahashi Hiromichi,Uchino Yoshihito,Kodaira Hitomi,Iriyama Noriyoshi,Sakagami Masashi,Ohtake Shimon,Kobayashi Sumiko,Hojo Atsuko,Kurita Daisuke,Kobayashi Yujin,Kusuda Machiko,Hirabayashi Yukio,Hatta Yoshihiro,Takei Masami

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-015-1926-6.pdf

Reference30 articles.

1. Yoshida M, Akiyama N, Fujita H, Miura K, Miyatake J, Handa H, et al. Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group. Int J Hematol. 2011;93:66–73.

2. Fujita H, Yoshida M, Miura K, Sano T, Kito K, Takahashi M, et al. Management of infection in patients with acute leukemia during chemotherapy in Japan: questionnaire analysis by the Japan Adult Leukemia Study Group. Int J Hematol. 2009;90:191–8.

3. Montassier E, Batard E, Gastinne T, Potel G, de La Cochetiere MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32:841–50.

4. Wang G, Hindler JF, Ward KW, Bruckner DA. Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period. J Clin Microbiol. 2006;44:3883–6.

5. Matsumoto K, Takesue Y, Ohmagari N, Mochizuki T, Mikamo H, Seki M, et al. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Infect Chemother. 2013;19:365–80.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Efficacy and Safety of Arbekacin against Pneumonia in Febrile Neutropenia: A Retrospective Study in Patients with Hematologic Malignancies;Infection & Chemotherapy;2022

2. Evaluation of once-daily dosing and target concentrations in therapeutic drug monitoring for arbekacin: A meta-analysis;Journal of Infection and Chemotherapy;2021-01

3. Increased Arbekacin Clearance in Patients With Febrile Neutropenia;Therapeutic Drug Monitoring;2020-02

4. Clinical Usefulness of Arbekacin;Infection & Chemotherapy;2016